Clinical Trials Logo
  1. Home
  2. Other
  3. NCT02021526

Triheptanoin (C7 Oil), a Food Supplement, for Glucose Transporter Type I Deficiency (G1D)

Glucose Transporter Type 1 Deficiency Syndrome Clinical Trial

Official title:
Treatment Development of Triheptanoin for Glucose Transporter Type I Deficiency

Clinical Trial Summary

This is a single-site, open-label, phase II trial of C7, a food supplement or medical food, for the development of treatment outcome measures for glucose transporter type I deficiency (G1D). The primary outcome measures are: 1. Safety and tolerability of C7 as measured by changes in comprehensive blood work, including lipid and free fatty acid panels, self-reported side effects and clinical exam; 2. Changes in brain metabolic rate by MRI and EEG measurements during C7 treatment; and 3. Maintenance of ketosis in G1D patients on ketogenic diet, as measured by serial ketone levels during treatment initiation.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02021526
Study type Interventional
Source University of Texas Southwestern Medical Center
Contact
Status Withdrawn
Phase Phase 1/Phase 2
Start date December 2015
Completion date June 2020
View Details
See also
  Status Clinical Trial Phase
Terminated NCT02599961 - Study to Assess the Long Term Safety and Efficacy of UX007 in Participants With Glucose Type 1 Deficiency Syndrome (Glut1 DS) Phase 2
Enrolling by invitation NCT03655223 - Early Check: Expanded Screening in Newborns
Recruiting NCT05085704 - Brain Metabolism Observed at 7 Tesla
Withdrawn NCT03202108 - Evaluation of Krio in Children and Adults With Epilepsy N/A
Active, not recruiting NCT04137692 - Red Blood Cell Exchange Transfusion as a Novel Treatment for GLUT1 Deficiency Syndrome N/A
Completed NCT03041363 - Treatment Development of Triheptanoin (G1D) Phase 1
Completed NCT02018315 - Treatment Development for Glucose Transporter Type I Deficiency Syndrome (G1D) Phase 1
Completed NCT04399954 - Evaluation of Ketoflo N/A
Recruiting NCT02013583 - The Glucose Transporter Type I Deficiency (G1D) Registry
Completed NCT02915211 - Evaluation of Keyo in Children With Epilepsy N/A
Active, not recruiting NCT02000960 - Pilot Study of Triheptanoin in Patients With Glucose Transporter 1 Deficiency Syndrome Phase 2
Active, not recruiting NCT03181399 - Diet Treatment Glucose Transporter Type 1 Deficiency (G1D) Phase 2
No longer available NCT02018302 - Post Study Continuation of C7 for G1D